
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Nigeria’s return to Windsor castle signals new era in UK economic partnership - 2
Melodic Combination d: A Survey of \Unrecorded Music Energy\ Show - 3
'Weezer: The Gathering' 2026 tour: How to get tickets, prices, dates and more - 4
Invigorating Spots To Go Kayaking All over The Planet - 5
The 10 Most Famous Works of art Ever
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
Examination In progress into Abuse of Japanese Government-Supported Advance
Unfathomable and Entertaining Legal disputes That Surprise everyone
IDF destroys regime's missile, sea mine production site in Yazd amid nationwide airstrikes
The most effective method to Begin Your Excursion in Gold Venture
A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
10 Setting up camp Shelters That Offer Both Excellence and Isolation













